Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Quest Diagnostics Inc. buy Citigroup Inc.

Start price
€129.80
10.07.24 / 50%
Target price
€152.36
10.07.25
Performance (%)
12.33%
End price
€145.80
11.07.25
Summary
This prediction ended on 11.07.25 with a price of €145.80. The prediction had a final performance of 12.33%. A total of €1.41 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Quest Diagnostics Inc. -1.309% -1.309% 2.624%
iShares Core DAX® 1.803% 0.496% 18.553%
iShares Nasdaq 100 0.429% -0.410% 8.908%
iShares Nikkei 225® 0.708% -3.799% 12.088%
iShares S&P 500 0.288% -0.218% 3.736%

Comments by Citigroup_Inc_ for this prediction

In the thread Quest Diagnostics Inc. diskutieren
Prediction Buy
Perf. (%) 12.33%
Target price 152.361
Change
Ends at 10.07.25

Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $165.00 price target on the stock, up previously from $145.00.
Ratings data for DGX provided by MarketBeat

In the thread Trading Quest Diagnostics Inc.
Prediction Buy
Perf. (%) 12.33%
Target price 152.361
Change
Ends at 10.07.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Citigroup_Inc_ for Quest Diagnostics Inc.

buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€146.25
23.10.24
€171.55
23.10.25
7.66%
24.10.25